Investigation of treatment failure in neonatal echovirus 7 infection

Pediatric Infectious Disease Journal

Volumn 25, Issue 3, 2006, Pages 259-262

  Rentz, Alison C ^a   Libbey, Jane E ^a   Fujinami, Robert S ^a   Whitby, Frank G ^a   Byington, Carrie L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Echovirus 7; Intravenous immunoglobulin; Neonatal enteroviral infection; Pleconaril

Indexed keywords

ACICLOVIR; AMPICILLIN; GENTAMICIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PLECONARIL;

ANIMAL CELL; ARTICLE; CASE REPORT; ECHO VIRUS; FATALITY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MATERNAL PLASMA; NEWBORN INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; VIRUS INFECTION; VIRUS ISOLATION;

ANTIVIRAL AGENTS; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MOLECULAR SEQUENCE DATA; OXADIAZOLES; SEQUENCE ANALYSIS, DNA; TREATMENT FAILURE;

EID: 33644930902     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000202071.38484.93     Document Type: Article

References (19)

1. Modlin JF. Update on enterovirus infections in infants and children. Adv Pediatr Infect Dis. 1996;12:155-180.
2. Abzug MJ, Levin MJ, Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J. 1993;12:820-824.
3. Dagan R, Prather SL, Powell KR, et al. Neutralizing antibodies to non-polio enteroviruses in human immune serum globulin. Pediatr Infect Dis J. 1983;2:454-456.
4. Hammond GW, Lukes H, Wells B, et al. Maternal and neonatal neutralizing antibody titers to selected enteroviruses. Pediatr Infect Dis J. 1985;4:32-35.
5. Nagington J, Wreghittt TG, Gandy G, et al. Fatal echovirus 11 infections in outbreak in special-care baby unit. Lancet. 1978;2(pt 1):725-728.
6. Carolane DJ, Long AM, McKeever PA, et al. Prevention of spread of echovirus 6 in a special care baby unit. Arch Dis Child. 1985;60:674-676.
7. Abzug MJ, Keyserling HL, Lee ML, et al. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis. 1995;20:1201-1206.
8. Rotbart HA, Webster AD. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis. 2001;32:228-235.
9. Bauer S, Gottesman G, Sirota L, et al. Severe Coxsackie virus B infection in preterm newborns treated with pleconaril. Eur J Pediatr. 2002;161:491-493.
10. Libbey JE, McCright IJ, Tsunoda I, et al. Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus. J Neurovirol. 2001;7:97-104.
11. Pevear DC, Tull TM, Seipel ME, et al. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. 1999;43:2109-2115.
12. Zurbriggen A, Fujinami RS. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J Virol. 1989;63:1505-1513.
13. Berman HM, Westbrook J, Feng Z, et al. The Protein Data Bank. Nucleic Acids Res. 2000;28:235-242.
14. Strikas RA, Anderson LJ, Parker RA. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis. 1986;153:346-351.
15. Enterovirus surveillance: United States, 2000-2001. MMWR. 2002;51: 1047-1049.
16. Chua BH, McMinn PC, Lam SK, et al. Comparison of the complete nucleotide sequences of echovirus 7 strain UMMC and the prototype (Wallace) strain demonstrates significant genetic drift over time. J Gen Virol. 2001;82:2629-2639.
17. Oberste MS, Maher K, Michele SM, et al. Enteroviruses 76, 89, 90, and 91 represent a novel group within the species human enterovirus A. J Gen Virol. 2005;(pt 2):445-451.
18. Groarke JM, Pevear DC. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. J Infect Dis. 1999;179:1538-1541.
19. Schmidtke M, Hammerschmidt E, Schuler S, et al. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrated the crucial role of amino acid 1092 in treatment. J Antimicrob Chemother. 2005;56:648-656.